Author:
Angevin Eric,Isambert Nicolas,Trillet-Lenoir Véronique,You Benoit,Alexandre Jérôme,Zalcman Gérard,Vielh Philippe,Farace Françoise,Valleix Fanny,Podoll Thomas,Kuramochi Yu,Miyashita Itaru,Hosono Osamu,Dang Nam H,Ohnuma Kei,Yamada Taketo,Kaneko Yutaro,Morimoto Chikao
Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. Amatya VJ, Takeshima Y, Kushitani K, Yamada T, Morimoto C, Inai K (2011) Overexpression of CD26/DPPIV in mesothelioma tissue and mesothelioma cell lines. Oncol Rep 26: 1369–1375.
2. Aoe K, Amatya VJ, Fujimoto N, Ohnuma K, Hosono O, Hiraki A, Fujii M, Yamada T, Dang NH, Takeshima Y, Inai K, Kishimoto T, Morimoto C (2012) CD26 overexpression is associated with prolonged survival and enhanced chemosensitivity in malignant pleural mesothelioma. Clin Cancer Res 18: 1447–1456.
3. Barreira da Silva R, Laird ME, Yatim N, Fiette L, Ingersoll MA, Albert ML (2015) Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy. Nat Immunol 16: 850–858.
4. Blayney JK, Ceresoli GL, Castagneto B, O’Brien ME, Hasan B, Sylvester R, Rudd R, Steele J, Busacca S, Porta C, Mutti L, O’Byrne KJ, Scullin P, Gaafar R, Baas P, Van Meerbeeck J, Fennell DA (2012) Response to chemotherapy is predictive in relation to longer overall survival in an individual patient combined-analysis with pleural mesothelioma. Eur J Cancer 48: 2983–29892.
5. Dang NH, Torimoto Y, Deusch K, Schlossman SF, Morimoto C (1990a) Comitogenic effect of solid-phase immobilized anti-1F7 on human CD4 T cell activation via CD3 and CD2 pathways. J Immunol 144: 4092–4100.
Cited by
57 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献